Myo Minn Oo

826 total citations
45 papers, 530 citations indexed

About

Myo Minn Oo is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Myo Minn Oo has authored 45 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 23 papers in Epidemiology and 9 papers in Virology. Recurrent topics in Myo Minn Oo's work include HIV/AIDS Research and Interventions (15 papers), Tuberculosis Research and Epidemiology (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (11 papers). Myo Minn Oo is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), Tuberculosis Research and Epidemiology (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (11 papers). Myo Minn Oo collaborates with scholars based in Myanmar, France and United States. Myo Minn Oo's co-authors include Nang Thu Thu Kyaw, Htun Nyunt Oo, Khine Wut Yee Kyaw, Peter F. Barnes, Petros Isaakidis, Akhilesh Kumar, Dajun Qian, Ajay Kumar, Jaya Prasad Tripathy and Anthony Harries and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Myo Minn Oo

41 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myo Minn Oo Myanmar 14 277 202 86 77 75 45 530
Caroline Ryan United States 15 288 1.0× 191 0.9× 142 1.7× 73 0.9× 46 0.6× 29 635
Cuong Duy Vietnam 15 360 1.3× 194 1.0× 113 1.3× 28 0.4× 115 1.5× 46 727
Alyssa S. Parpia United States 13 269 1.0× 99 0.5× 103 1.2× 68 0.9× 32 0.4× 24 719
Mônica Derrico Brazil 15 281 1.0× 215 1.1× 166 1.9× 24 0.3× 38 0.5× 21 534
Pablo Montoya United States 12 424 1.5× 180 0.9× 185 2.2× 139 1.8× 128 1.7× 23 615
Mariam Siddiqui United States 14 128 0.5× 200 1.0× 68 0.8× 63 0.8× 122 1.6× 23 845
Dyah Erti Mustikawati Indonesia 12 298 1.1× 253 1.3× 92 1.1× 38 0.5× 48 0.6× 18 421
Joanne McManus United Kingdom 5 136 0.5× 107 0.5× 92 1.1× 72 0.9× 26 0.3× 9 439
Luis Sagaon‐Teyssier France 16 399 1.4× 414 2.0× 193 2.2× 63 0.8× 64 0.9× 72 866
Reshma Kassanjee South Africa 17 474 1.7× 271 1.3× 181 2.1× 40 0.5× 302 4.0× 48 939

Countries citing papers authored by Myo Minn Oo

Since Specialization
Citations

This map shows the geographic impact of Myo Minn Oo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myo Minn Oo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myo Minn Oo more than expected).

Fields of papers citing papers by Myo Minn Oo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myo Minn Oo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myo Minn Oo. The network helps show where Myo Minn Oo may publish in the future.

Co-authorship network of co-authors of Myo Minn Oo

This figure shows the co-authorship network connecting the top 25 collaborators of Myo Minn Oo. A scholar is included among the top collaborators of Myo Minn Oo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myo Minn Oo. Myo Minn Oo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oo, Myo Minn, Sahan Jayawardana, Allen Campbell, et al.. (2025). Trends in global glucose lowering medication consumption: Insights from pharmaceutical sales data (2010–2021). PLOS Global Public Health. 5(10). e0005326–e0005326.
2.
Mishra, Sharmistha, Kevin Gough, Charlie Tan, et al.. (2025). Early clinical experience using tecovirimat during the 2022 mpox epidemic in Toronto underscores ongoing clinical equipoise and the need for randomized trials. Journal of Antimicrobial Chemotherapy. 80(4). 935–940. 1 indexed citations
3.
Oo, Myo Minn, Katherine K. Thomas, Connie Celum, et al.. (2024). Pre–Human Immunodeficiency Virus (HIV) α4β7hi CD4+ T Cells and HIV Risk Among Heterosexual Individuals in Africa. The Journal of Infectious Diseases. 231(4). e770–e780. 1 indexed citations
5.
Xie, Min, Myo Minn Oo, Mark Hansen, et al.. (2023). Wild mouse gut microbiota limits initial tuberculosis infection in BALB/c mice. PLoS ONE. 18(7). e0288290–e0288290. 1 indexed citations
8.
Kyaw, Khine Wut Yee, Nang Thu Thu Kyaw, Ajay Kumar, et al.. (2019). Initiation of antiretroviral therapy or antiretroviral prophylaxis in pregnant women living with HIV registered in five townships of Mandalay, Myanmar: A cross sectional study. BMC Pregnancy and Childbirth. 19(1). 475–475. 4 indexed citations
9.
Dorji, Thinley, et al.. (2019). “If we miss this chance, it’s futile later on” – late antenatal booking and its determinants in Bhutan: a mixed-methods study. BMC Pregnancy and Childbirth. 19(1). 158–158. 19 indexed citations
10.
Kyaw, Nang Thu Thu, Srinath Satyanarayana, Ajay Kumar, et al.. (2019). Outcomes of Community-Based Systematic Screening of Household Contacts of Patients with Multidrug-Resistant Tuberculosis in Myanmar. Tropical Medicine and Infectious Disease. 5(1). 2–2. 4 indexed citations
11.
Kyaw, Nang Thu Thu, et al.. (2018). Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis. Global Health Action. 11(1). 1510593–1510593. 12 indexed citations
12.
Kyaw, Khine Wut Yee, Srinath Satyanarayana, Nang Thu Thu Kyaw, et al.. (2018). Uptake of antiretroviral therapy in HIV-positive women ever enrolled into ‘prevention of mother to child transmission’ programme, Mandalay, Myanmar—a cohort study. BMC Pregnancy and Childbirth. 18(1). 474–474. 3 indexed citations
13.
Pyakurel, Prajjwal, Jaya Prasad Tripathy, Myo Minn Oo, et al.. (2018). Catastrophic health expenditure among industrial workers in a large-scale industry in Nepal, 2017: a cross-sectional study. BMJ Open. 8(11). e022002–e022002. 8 indexed citations
14.
Oo, Myo Minn, et al.. (2018). HIV, HBV and HCV in people who inject drugs and are placed on methadone maintenance therapy, Yangon, Myanmar. Public Health Action. 8(4). 202–210. 7 indexed citations
15.
Kyaw, Nang Thu Thu, Ajay Kumar, Myo Minn Oo, et al.. (2017). Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar. Global Health Action. 10(1). 1290916–1290916. 17 indexed citations
16.
Shewade, Hemant Deepak, Sairu Philip, Nang Thu Thu Kyaw, et al.. (2017). Factors associated with long turnaround time for early infant diagnosis of HIV in Myanmar. Global Health Action. 10(1). 1395657–1395657. 10 indexed citations
17.
Kyaw, Khine Wut Yee, et al.. (2017). Low mother-to-child HIV transmission rate but high loss-to-follow-up among mothers and babies in Mandalay, Myanmar; a cohort study. PLoS ONE. 12(9). e0184426–e0184426. 23 indexed citations
18.
Kyaw, Nang Thu Thu, Anthony Harries, Ajay Kumar, et al.. (2017). High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015. PLoS ONE. 12(2). e0171780–e0171780. 43 indexed citations
19.
Shewade, Hemant Deepak, Sairu Philip, Nang Thu Thu Kyaw, et al.. (2017). Early infant diagnosis of HIV in Myanmar: call for innovative interventions to improve uptake and reduce turnaround time. Global Health Action. 10(1). 1319616–1319616. 11 indexed citations
20.
Thi, Aung, Hemant Deepak Shewade, Nang Thu Thu Kyaw, et al.. (2016). Timing of antiretroviral therapy and TB treatment outcomes in patients with TB-HIV in Myanmar. Public Health Action. 6(2). 111–117. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026